Potency of Δ9 -tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacology-Reference-Cited by-同舟云学术

Potency of Δ9 -tetrahydrocannabinol and other cannabinoids in cannabis in England in 2016: Implications for public health and pharmacology

Published:2018-02-27 Issue:4 Volume:10 Page:628-635
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test Anal

Author:

Potter David J.¹^ORCID,Hammond Kathy¹,Tuffnell Shaun¹,Walker Christopher²,Di Forti Marta³^ORCID

Affiliation:

1. GW Pharmaceuticals plc; Cambridge UK

2. Drug Control Centre; Kings College London; UK

3. Institute of Psychiatry Psychology and Neuroscience; Department of Social Genetic and Developmental Psychiatry (SGDP), Kings College London; UK

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Reference39 articles.

1. Hargreaves J Smith K Home Office National Statistics, Seizures of Drugs in England and Wales https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/564412/seizures-drugs-hosb1316.pdf

2. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people;Henquet;BMJ,2004

3. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review;Moore;Lancet,2007

4. High-potency cannabis and the risk of psychosis;Di Forti;Br J Psychiatry,2009

5. Cannabis use and earlier onset of psychosis: a systematic meta-analysis;Large;Arch Gen Psychiatry,2011

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between cannabis potency and mental health in adolescence;Drug and Alcohol Dependence;2024-08

2. Phytocannabinoid profile and potency of cannabis resin (hashish) of northwest Himalayas of India;Journal of Forensic Sciences;2024-07-11

3. Exploring causal mechanisms of psychosis risk;Neuroscience & Biobehavioral Reviews;2024-07

4. Applying machine learning to international drug monitoring: classifying cannabis resin collected in Europe using cannabinoid concentrations;European Archives of Psychiatry and Clinical Neuroscience;2024-05-21

5. Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study;European Archives of Psychiatry and Clinical Neuroscience;2024-05-06